WELLINGTON MANAGEMENT GROUP LLP - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 151 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q4 2021$824,000
-50.7%
756,169
+154.6%
0.00%
Q3 2016$1,672,000
-19.9%
296,974
-21.9%
0.00%
-100.0%
Q2 2016$2,088,000
-36.8%
380,375
-14.6%
0.00%0.0%
Q1 2016$3,306,000
+6.8%
445,636
+19.6%
0.00%0.0%
Q4 2015$3,096,000372,5730.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
MSD Partners, L.P. 15,151,516$38,182,0007.99%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 10,406,850$26,225,0004.02%
MILLER VALUE PARTNERS, LLC 12,385,586$31,211,0001.12%
CHIRON CAPITAL MANAGEMENT, LLC 201,470$508,0000.41%
Sargent Investment Group, LLC 289,025$728,0000.26%
MAGNOLIA CAPITAL ADVISORS LLC 80,542$404,0000.16%
XTX MARKETS LLC 11,086$28,0000.14%
Virtus ETF Advisers LLC 99,108$250,0000.13%
Old West Investment Management, LLC 210,226$529,0000.12%
EQUITEC PROPRIETARY MARKETS, LLC 31,300$79,0000.06%
View complete list of ZIOPHARM ONCOLOGY INC shareholders